BCART Biocartis Group NV

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 09 May 2024, 07:00 CEST

Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

Mechelen, Belgium, 09 May 2024 – Biocartis Group NV (the "Company") (Euronext Brussels: BCART), announces today that it has decided to postpone the publication of its 2023 Annual Report, in view of the ongoing preparation of the contemplated voluntary dissolution and liquidation of the Company, which will be submitted to an extraordinary general shareholders’ meeting (“EGM”) for approval.

For the same reason, the publication of the convening notice for the Company's annual general shareholders’ meeting (“AGM”) and the date of the AGM (which was initially envisaged to take place on 10 May 2024) will be postponed.

The Company will continue to update the market as appropriate, and will announce at a later date the publication of the 2023 Annual Report and the convening of the AGM and EGM.

----- END -----

More information:

Investor Relations Biocartis Group NV

e-mail 





EN
09/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Biocartis Group NV

 PRESS RELEASE

Press release Biocartis Group NV: Biocartis Group NV provides an updat...

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 09 May 2024, 07:00 CEST Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting Mechelen, Belgium, 09 May 2024 – Biocartis Group NV (the "Company") (Euronext Brussels: BCART), announces today that it has decided to postpone the publication of its 2023 Annual Report, in view of the ongoing preparation of the contem...

 PRESS RELEASE

Persbericht Biocartis Group NV: Biocartis Group NV brengt een update r...

Persbericht Biocartis Group NV: Biocartis Group NV brengt een update rond de publicatie van haar jaarverslag en de jaarlijkse algemene vergadering BIOCARTIS GROUP NV (Euronext Brussels: BCART) PERSBERICHT - GEREGULEERDE INFORMATIE - 09 mei 2024, 07:00 CEST Biocartis Group NV brengt een update rond de publicatie van haar jaarverslag en de jaarlijkse algemene vergadering Mechelen, België, 09 mei 2024 – Biocartis Group NV (de "Vennootschap") (Euronext Brussels: BCART), kondigt vandaag aan dat zij beslist heeft de publicatie van haar 2023 Jaarverslag uit te stellen, in het licht van de lopen...

 PRESS RELEASE

Press release Biocartis Group NV: Disclosure of transparency notificat...

Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings) BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings) 1. Summary of notice BIOCARTIS GROUP NV received a transparency notification on January 5, 2024, of which an amended version was received on January 8, 2024, showing that...

 PRESS RELEASE

Press release Biocartis Group NV: Disclosure of transparency notificat...

Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings) BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings) 1. Summary of notice BIOCARTIS GROUP NV received a transparency notification on January 5, 2024, showing that JPMorgan Chase & Co., with registered office a...

 PRESS RELEASE

Press release Biocartis Holdings Inc.: Recapitalization completed and ...

Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion PRESS RELEASE - 22 November 2023, 10:00 CET BIOCARTIS HOLDINGS INC. RECAPITALIZATION COMPLETED AND PRODUCT PORTFOLIO EXPANSION The recapitalization of Biocartis was completed last week, strengthening the balance sheet with a new investment of €40 million and a €132 million conversion of debt to equity.Product portfolio expansion with the launch of three breast cancer products: the Idylla™ PIK3CA-AKT1 Mutation Assay and, in collaboration with our partner APIS, the APIS Breast Cancer Subtyping...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch